Lack of adipose-specific hexose-6-phosphate dehydrogenase causes inactivation of adipose glucocorticoids and improves metabolic phenotype in mice.
Lack of adipose-specific hexose-6-phosphate dehydrogenase causes inactivation of adipose glucocorticoids and improves metabolic phenotype in mice.
复制标题
缺乏脂肪特异性六磷酸己糖脱氢酶会导致脂肪糖皮质激素失活并改善小鼠的代谢表型。
DOI:
10.1042/cs20190679
复制
发表时间:
2019
期刊:
影响因子:
--
通讯作者:
Liu,Yanjun
中科院分区:
文献类型:
--
作者:
Wang,Jian;Wang,Ying;Liu,Limei;Lutfy,Kabirullah;Friedman,TheodoreC;Liu,Ya;Jiang,Meisheng;Liu,Yanjun
Excessive glucocorticoid (GC) production in adipose tissue promotes the development of visceral obesity and metabolic syndrome (MS). 11β-hydroxysteroid dehydrogenase type 1 (11β-HSD1) is critical for controlling intracellular GC production, and this process is tightly regulated by hexose-6-phosphate dehydrogenase (H6PDH). To better understand the integrated molecular physiological effects of adipose H6PDH, we created a tissue-specific knockout of the H6PDH gene mouse model in adipocytes (adipocyte-specific conditional knockout of H6PDH (H6PDHAcKO) mice). H6PDHAcKOmice exhibited almost complete absence of H6PDH expression and decreased intra-adipose corticosterone production with a reduction in 11β-HSD1 activity in adipose tissue. These mice also had decreased abdominal fat mass, which was paralleled by decreased adipose lipogenic acetyl-CoA carboxylase (ACC) and ATP-citrate lyase (ACL) gene expression and reduction in their transcription factor C/EBPα mRNA levels. Moreover, H6PDHAcKOmice also had reduced fasting blood glucose levels, increased glucose tolerance, and increased insulin sensitivity. In addition, plasma free fatty acid (FFA) levels were decreased with a concomitant decrease in the expression of lipase adipose triglyceride lipase (ATGL) and hormone-sensitive lipase (HSL) in adipose tissue. These results indicate that inactivation of adipocyte H6PDH expression is sufficient to cause intra-adipose GC inactivation that leads to a favorable pattern of metabolic phenotypes. These data suggest that H6PDHAcKOmice may provide a good model for studying the potential contributions of fat-specific H6PDH inhibition to improve the metabolic phenotypein vivo. Our study suggests that suppression or inactivation of H6PDH expression in adipocytes could be an effective intervention for treating obesity and diabetes.
登录
查看更多内容
影响因子:
2.9
作者:
E. Torrecilla;G. Fernández;D. Vicent;F. Sánchez‐Franco;A. Barabash;L. Cabrerizo;A. Sánchez;A. Torres;M. Rubio
通讯作者:
M. Rubio
DOI:
--
发表时间:
2008
期刊:
Biochemical and Biophysical Research Communications - BBRC
影响因子:
--
作者:
B. Ganesh Bhat;H. Younis;J. Herrera;Kimbie Palacio;Bernadette Pascual;George Hur;B. Jessen;Kathleen M. Ogilvie;P. Rejto
通讯作者:
P. Rejto
影响因子:
4.8
作者:
McCormick, KL;Wang, XD;Mick, GJ
通讯作者:
Mick, GJ
DOI:
10.18544/pedm-23.01.0073
发表时间:
2017
期刊:
Pediatric endocrinology, diabetes, and metabolism
影响因子:
--
作者:
A. Zajkowska;M. Rydzewska;Katarzyna Wojtkielewicz;J. Pomaski;T. Romer;A. Bossowski
通讯作者:
A. Bossowski
影响因子:
4.8
作者:
Odermatt, A;Arnold, P;Frey, FJ
通讯作者:
Frey, FJ